Quantification of fragments of human serum inter-α-trypsin inhibitor heavy chain 4 by a surface-enhanced laser desorption/ionization-based immunoassay

Clinical Chemistry

Volumn 52, Issue 6, 2006, Pages 1045-1053

  Song, Jin ^a   Patel, Manisha ^a   Rosenzweig, C Nicole ^a   Chan Li, Yee ^a   Sokoll, Lori J ^a   Fung, Eric T ^b   Choi Miura, Nam Ho ^c   Goggins, Michael ^a   Chan, Daniel W ^a   Zhang, Zhen ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b CIPHERGEN BIOSYSTEMS INC   (United States)

^c SHOWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INTER ALPHA TRYPSIN INHIBITOR; INTER ALPHA TRYPSIN INHIBITOR HEAVY CHAIN 4; PEPTIDE; PLASMA PROTEIN; PROTEIN; PROTEINASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; CANCER; CONTROLLED STUDY; FEMALE; HEAVY CHAIN; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADULT; AGED; AMINO ACID SEQUENCE; BLOOD PROTEINS; BREAST NEOPLASMS; COLONIC NEOPLASMS; DIABETES MELLITUS; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROSTATIC NEOPLASMS; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERUM; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33646909090     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.065722     Document Type: Article

References (32)

1. Pu XP, Iwamoto A, Nishimura H, Nagasawa S. Purification and characterization of a novel substrate for plasma kallikrein (PK-120) in human plasma. Biochim Biophys Acta 1994;1208:338-43.
2. Nishimura H, Kakizaki I, Muta T, Sasaki N, Pu PX, Yamashita T, et al. cDNA and deduced amino acid sequence of human PK-120, a plasma kallikrein-sensitive glycoprotein. FEBS Lett 1995;357:207-11.
3. Choi-Miura NH, Sano Y, Oda E, Nakano Y, Tobe T, Yanagishita T, et al. Purification and characterization of a novel glycoprotein which has significant homology to heavy chains of inter-α-trypsin inhibitor family from human plasma. J Biochem (Tokyo) 1995;117:400-7.
4. Soury E, Olivier E, Daveau M, Hiron M, Claeyssens S, Risler JL, et al. The H4P heavy chain of inter-α-inhibitor family largely differs in the structure and synthesis of its prolin-rich region from rat to human. Biochem Biophys Res Commun 1998;243:522-30.
5. Choi-Miura NH. Quantitative measurement of the novel human plasma protein, IHRP, by sandwich ELISA. Biol Pharm Bull 2001;24:214-7.
6. Choi-Miura NH, Takahashi K, Yoda M, Saito K, Hori M, Ozaki H, et al. The novel acute phase protein, IHRP, inhibits actin polymerization and phagocytosis of polymorphonuclear cells. Inflamm Res 2000;49:305-10.
7. Daveau M, Jean L, Soury E, Olivier E, Masson S, Lyoumi S, et al. Hepatic and extra-hepatic transcription of inter-α-inhibitor family genes under normal or acute inflammatory conditions in rat. Arch Biochem Biophys 1998;350:315-23.
8. Gonzalez-Ramon N, Hoebe K, Alava MA, Van Leengoed L, Pineiro M, Carmona S, et al. Pig MAP/ITIH4 and haptoglobin are interleukin-6-dependent acute-phase plasma proteins in porcine primary cultured hepatocytes. Eur J Biochem 2000;267:1878-85.
9. Gonzalez-Ramon N, Alava MA, Sarsa JA, Pineiro M, Escartin A, Garcia-Gil A, et al. The major acute phase serum protein in pigs is homologous to human plasma kallikrein sensitive PK-120. FEBS Lett 1995;371:227-30.
10. Pineiro M, Andres M, Iturralde M, Carmona S, Hirvonen J, Pyorala S, et al. ITIH4 (inter-α-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection. Infect Immun 2004;72:3777-82.
11. Pineiro M, Alava MA, Gonzalez-Ramon N, Osada J, Lasierra P, Larrad L, et al. ITIH4 serum concentration increases during acute-phase processes in human patients and is up-regulated by interleukin-6 in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun 1999;263:224-9.
12. Salier JP, Rouet P, Raguenez G, Daveau M. The inter-α-inhibitor family, from structure to regulation. Biochem J 1996;315(Pt 1):1-9.
13. Bost F, Diarra-Mehrpour M, Martin JP. Inter-α-trypsin inhibitor proteoglycan family-a group of proteins binding and stabilizing the extracellular matrix. Eur J Biochem 1998;252:339-46.
14. Saguchi K, Tobe T, Hashimoto K, Sano Y, Nakano Y, Miura NH, et al. Cloning and characterization of cDNA for inter-α-trypsin inhibitor family heavy chain-related protein (IHRP), a novel human plasma glycoprotein. J Biochem (Tokyo) 1995;117:14-8.
15. Hashimoto K, Tobe T, Sumiya J, Sano Y, Choi-Miura NH, Ozawa A, et al. Primary structure of the pig homologue of human IHRP: inter-α-trypsin inhibitor family heavy chain-related protein. J Biochem (Tokyo) 1996;119:577-84.
16. Zhang Z, Bast RCJ, Yu Y, Li J, Sokoll U, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res 2004;64:5882-90.
17. Fung ET, Yip TT, Lomas L, Wang Z, Yip C, Meng XY, et al. Classification of cancer types by measuring variants of host response proteins using SELDI serum assays. Int J Cancer 2005;115:783-9.
18. Caputo E, Lombardi ML, Luongo V, Moharram R, Tornatore P, Pirozzi G, et al. Peptide profiling in epithelial tumor plasma by the emerging proteomic techniques. J Chromatogr B Analyt Technol Biomed Life Sci 2005;819:59-66.
19. Koomen JM, Shin LN, Coombes KR, Li D, Xiao LC, Fidler IJ, et al. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 2005;11:1110-8.
20. Villanueva J, Shaffer DR, Philip J, Chaparro CA, Erdjument-Bromage H, Olshen AB, et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J Clin Invest 2006;116:271-84.
21. Koomen JM, Li D, Xiao LC, Liu TC, Coombes KR, Abbruzzese J, et al. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. J Proteome Res 2005;4:972-81.
22. Busek P, Malik R, Sedo A. Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer. Int J Biochem Cell Biol 2004;36:408-21.
23. Proost P, De Meester I, Schols D, Struyf S, Lambeir AM, Wuyts A, et al. Amino-terminal truncation of chemokines by CD26/dipeptidyl-peptidase IV. Conversion of RANTES into a potent inhibitor of monocyte chemotaxis and HIV-1-infection. J Biol Chem 1998;273:7222-7.
24. Walsh DA, Mapp PI, Wharton J, Polak JM, Blake DR. Neuropeptide degrading enzymes in normal and inflamed human synovium. Am J Pathol 1993;142:1610-21.
25. Juillerat-Jeanneret L, Aubert JD, Leuenberger P. Peptidases in human bronchoalveolar lining fluid, macrophages, and epithelial cells: dipeptidyl (amino)peptidase IV, aminopeptidase N, and dipeptidyl (carboxy)peptidase (angiotensin-converting enzyme). J Lab Clin Med 1997;130:603-14.
26. 2S. Joseph K, Kaplan AP. Formation of bradykinin: a major contributor to the innate inflammatory response. Adv Immunol 2005;86:159-208.
27. 2T. Lefebvre J, Murphey LJ, Hartert TV, Jiao Shan R, Simmons WH, Brown NJ. Dipeptidyl peptidase IV activity in patients with ACE-inhibitor-associated angioedema. Hypertension 2002;39:460-4.
28. Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics 2004;3:367-78.
29. 2-microglobulin in serum from patients undergoing chronic hemodialysis. Clin Chem 2005;51:1177-84.
30. Matrisian LM, Sledge GW Jr, Mohla S. Extracellular proteolysis and cancer: meeting summary and future directions. Cancer Res 2003;63:6105-9.
31. Bank U, Kruger S, Langner J, Roessner A. Review: peptidases and peptidase inhibitors in the pathogenesis of diseases. Distur bances in the ubiquitin-mediated proteolytic system. Protease-antiprotease imbalance in inflammatory reactions. Role of cathepsins in tumour progression. Adv Exp Med Biol 2000;477:349-78.
32. Zhang Z, Chan DW. Cancer proteomics: in pursuit of "true" biomarker discovery. Cancer Epidemiol Biomarkers Prev 2005;14 2283-6.